Patents by Inventor ANAIS MOCKEL

ANAIS MOCKEL has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS AND METHODS FOR THE TREATMENT OF RETINAL DEGENERATION
    Publication number: 20170231930
    Abstract: The present invention relates to a pharmaceutical composition comprising an inhibitor of eIF2?, a compound increasing the expression and/or activity of protein BiP and/or an inhibitor of Caspase-12, preferably an inhibitor of eIF2? and a compound increasing the expression and/or activity of protein BiP. The present invention also relates to pharmaceutical compositions and methods for treating retinal degeneration related to ciliary dysfunction.
    Type: Application
    Filed: May 1, 2017
    Publication date: August 17, 2017
    Inventors: VINCENT MARION, ANAIS MOCKEL, HELENE DOLLFUS
  • Compositions and methods for the treatment of retinal degeneration
    Patent number: 9636377
    Abstract: The present invention relates to a pharmaceutical composition comprising an inhibitor of eIF2?, a compound increasing the expression and/or activity of protein BiP and/or an inhibitor of Caspase-12, preferably an inhibitor of eIF2? and a compound increasing the expression and/or activity of protein BiP. The present invention also relates to pharmaceutical compositions and methods for treating retinal degeneration related to ciliary dysfunction.
    Type: Grant
    Filed: February 25, 2013
    Date of Patent: May 2, 2017
    Assignee: UNIVERSITE DE STRASBOURG
    Inventors: Vincent Marion, Anaïs Mockel, Hélène Dollfus
  • COMPOSITIONS AND METHODS FOR THE TREATMENT OF RETINAL DEGENERATION
    Publication number: 20150038432
    Abstract: The present invention relates to a pharmaceutical composition comprising an inhibitor of eIF2?, a compound increasing the expression and/or activity of protein BiP and/or an inhibitor of Caspase-12, preferably an inhibitor of eIF2? and a compound increasing the expression and/or activity of protein BiP. The present invention also relates to pharmaceutical compositions and methods for treating retinal degeneration related to ciliary dysfunction.
    Type: Application
    Filed: February 25, 2013
    Publication date: February 5, 2015
    Applicant: UNIVERSITE DE STRASBOURG
    Inventors: Vincent Marion, Anaïs Mockel, Hélène Dollfus